ALK and anaplastic large cell lymphoma: Excluding ALK + ALCL, a post hoc analysis showed improved PFS with consolidative autologous stem cell transplant in patients who achieved a CR after CHP-brentuximab vedotin, including in the subset of ALK − ALCL patients [21].